Timing of VV‐ECMO therapy implementation influences prognosis of COVID‐19 patients

INTRODUCTION: Current knowledge on the use of extracorporeal membrane oxygenation (ECMO) in COVID‐19 remains limited to small series and registry data. In the present retrospective monocentric study, we report on our experience, our basic principles, and our results in establishing and managing ECMO...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Physiol Rep
Main Authors: Giraud, Raphaël, Legouis, David, Assouline, Benjamin, De Charriere, Amandine, Decosterd, Dumeng, Brunner, Marie‐Eve, Moret‐Bochatay, Mallory, Fumeaux, Thierry, Bendjelid, Karim
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2021
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7851435/
https://ncbi.nlm.nih.gov/pubmed/33527751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.14715
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares